Records containing: IgG4 Related Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-17Prospective Diagnostic Performance of PET/CT Using the Novel Fibroblast Imaging Tracer [18F]-AlF-FAPI-74 Versus Standard of Care [18F]-FDG in Inflammatory Disorders
-
CLINICAL_TRIALS study record update · 2026-04-01A Phase II, Single-Site, Open-Label Study of Zanubrutinib in Patients With IgG4-Related Disease
-
CLINICAL_TRIALS study record update · 2026-02-13Phase 1b/2a Prospective, Open Label, Multicenter, Single Arm Study to Assess Safety, Efficacy and Persistence of ACE1831, in Subjects With Immunoglobulin G4-Related Disease
-
CLINICAL_TRIALS study record update · 2026-02-04A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Obexelimab in Patients With IgG4-Related Disease (INDIGO)
-
CLINICAL_TRIALS study record update · 2025-12-30A Randomized Controlled Study of the Efficacy and Safety of Lenalidomide in the Treatment of Active IgG4-RD
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-12-23An Exploratory Clinical Study on the Safety and Efficacy of CD19/BCMA CAR-NK (KN5601) in the Treatment of Relapsed and Refractory IgG4-related Disease (IgG4-RD)
-
CLINICAL_TRIALS study record update · 2025-09-03Exploratory Clinical Study of Anti-BCMA-CD19 CAR-T Cell Therapy for Relapsed/Refractory IgG4-Related Disease
-
CLINICAL_TRIALS study record update · 2025-06-25A Phase 3, Randomized, Double-blind, Multicenter, Placebo Controlled Study of Inebilizumab Efficacy and Safety in IgG4-Related Disease
-
CLINICAL_TRIALS study record update · 2025-04-30Identification of Adaptive and Trained Immune Mechanisms Driving Tissue Fibrosis in IgG4-Related Disease
-
CLINICAL_TRIALS study record update · 2025-02-25Elotuzumab in Immunoglobulin G4-Related Disease (IgG4-RD)
-
CLINICAL_TRIALS study record update · 2024-04-15Early Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory
-
CLINICAL_TRIALS study record update · 2023-02-15A Single-arm Study Sponsored by Investigators to Evaluate the Efficacy and Safety of CM310 Recombinant Humanized Monoclonal Antibody Injection in Patients With Recurrent IgG4-related Diseases
-
CLINICAL_TRIALS study record update · 2023-02-08Impact of COVID-19 on the Clinical Outcomes and Management of IgG4 Related Disease Patients With Pancreatobiliary Involvement: a Multicenter Retrospective Study